Global Alpha Thalassemia Market Growth (Status and Outlook) 2022-2028
- LP 4844094
- 62 Pages
- February 2022
- Medical Devices
The United States Alpha Thalassemia market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Alpha Thalassemia market, reaching US$ million by the year 2028. As for the Europe Alpha Thalassemia landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Alpha Thalassemia players cover Bluebird Bio, Novartis, Kiadis Pharma, and Acceleron Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Alpha Thalassemia market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Iron Chelating Drugs
Gene Therapy
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Private Clinics
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Bluebird Bio
Novartis
Kiadis Pharma
Acceleron Pharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Alpha Thalassemia Market Size 2017-2028
2.1.2 Alpha Thalassemia Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Alpha Thalassemia Segment by Type
2.2.1 Iron Chelating Drugs
2.2.2 Gene Therapy
2.3 Alpha Thalassemia Market Size by Type
2.3.1 Alpha Thalassemia Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Alpha Thalassemia Market Size Market Share by Type (2017-2022)
2.4 Alpha Thalassemia Segment by Application
2.4.1 Hospitals
2.4.2 Private Clinics
2.4.3 Other
2.5 Alpha Thalassemia Market Size by Application
2.5.1 Alpha Thalassemia Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Alpha Thalassemia Market Size Market Share by Application (2017-2022)
3 Alpha Thalassemia Market Size by Player
3.1 Alpha Thalassemia Market Size Market Share by Players
3.1.1 Global Alpha Thalassemia Revenue by Players (2020-2022)
3.1.2 Global Alpha Thalassemia Revenue Market Share by Players (2020-2022)
3.2 Global Alpha Thalassemia Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Alpha Thalassemia by Regions
4.1 Alpha Thalassemia Market Size by Regions (2017-2022)
4.2 Americas Alpha Thalassemia Market Size Growth (2017-2022)
4.3 APAC Alpha Thalassemia Market Size Growth (2017-2022)
4.4 Europe Alpha Thalassemia Market Size Growth (2017-2022)
4.5 Middle East & Africa Alpha Thalassemia Market Size Growth (2017-2022)
5 Americas
5.1 Americas Alpha Thalassemia Market Size by Country (2017-2022)
5.2 Americas Alpha Thalassemia Market Size by Type (2017-2022)
5.3 Americas Alpha Thalassemia Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Alpha Thalassemia Market Size by Region (2017-2022)
6.2 APAC Alpha Thalassemia Market Size by Type (2017-2022)
6.3 APAC Alpha Thalassemia Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Alpha Thalassemia by Country (2017-2022)
7.2 Europe Alpha Thalassemia Market Size by Type (2017-2022)
7.3 Europe Alpha Thalassemia Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Alpha Thalassemia by Region (2017-2022)
8.2 Middle East & Africa Alpha Thalassemia Market Size by Type (2017-2022)
8.3 Middle East & Africa Alpha Thalassemia Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Alpha Thalassemia Market Forecast
10.1 Global Alpha Thalassemia Forecast by Regions (2023-2028)
10.1.1 Global Alpha Thalassemia Forecast by Regions (2023-2028)
10.1.2 Americas Alpha Thalassemia Forecast
10.1.3 APAC Alpha Thalassemia Forecast
10.1.4 Europe Alpha Thalassemia Forecast
10.1.5 Middle East & Africa Alpha Thalassemia Forecast
10.2 Americas Alpha Thalassemia Forecast by Country (2023-2028)
10.2.1 United States Alpha Thalassemia Market Forecast
10.2.2 Canada Alpha Thalassemia Market Forecast
10.2.3 Mexico Alpha Thalassemia Market Forecast
10.2.4 Brazil Alpha Thalassemia Market Forecast
10.3 APAC Alpha Thalassemia Forecast by Region (2023-2028)
10.3.1 China Alpha Thalassemia Market Forecast
10.3.2 Japan Alpha Thalassemia Market Forecast
10.3.3 Korea Alpha Thalassemia Market Forecast
10.3.4 Southeast Asia Alpha Thalassemia Market Forecast
10.3.5 India Alpha Thalassemia Market Forecast
10.3.6 Australia Alpha Thalassemia Market Forecast
10.4 Europe Alpha Thalassemia Forecast by Country (2023-2028)
10.4.1 Germany Alpha Thalassemia Market Forecast
10.4.2 France Alpha Thalassemia Market Forecast
10.4.3 UK Alpha Thalassemia Market Forecast
10.4.4 Italy Alpha Thalassemia Market Forecast
10.4.5 Russia Alpha Thalassemia Market Forecast
10.5 Middle East & Africa Alpha Thalassemia Forecast by Region (2023-2028)
10.5.1 Egypt Alpha Thalassemia Market Forecast
10.5.2 South Africa Alpha Thalassemia Market Forecast
10.5.3 Israel Alpha Thalassemia Market Forecast
10.5.4 Turkey Alpha Thalassemia Market Forecast
10.5.5 GCC Countries Alpha Thalassemia Market Forecast
10.6 Global Alpha Thalassemia Forecast by Type (2023-2028)
10.7 Global Alpha Thalassemia Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Bluebird Bio
11.1.1 Bluebird Bio Company Information
11.1.2 Bluebird Bio Alpha Thalassemia Product Offered
11.1.3 Bluebird Bio Alpha Thalassemia Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Bluebird Bio Main Business Overview
11.1.5 Bluebird Bio Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Alpha Thalassemia Product Offered
11.2.3 Novartis Alpha Thalassemia Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Kiadis Pharma
11.3.1 Kiadis Pharma Company Information
11.3.2 Kiadis Pharma Alpha Thalassemia Product Offered
11.3.3 Kiadis Pharma Alpha Thalassemia Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Kiadis Pharma Main Business Overview
11.3.5 Kiadis Pharma Latest Developments
11.4 Acceleron Pharma
11.4.1 Acceleron Pharma Company Information
11.4.2 Acceleron Pharma Alpha Thalassemia Product Offered
11.4.3 Acceleron Pharma Alpha Thalassemia Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Acceleron Pharma Main Business Overview
11.4.5 Acceleron Pharma Latest Developments
12 Research Findings and Conclusion
Table 1. Alpha Thalassemia Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Iron Chelating Drugs
Table 3. Major Players of Gene Therapy
Table 4. Alpha Thalassemia Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Alpha Thalassemia Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Alpha Thalassemia Market Size Market Share by Type (2017-2022)
Table 7. Alpha Thalassemia Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Alpha Thalassemia Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Alpha Thalassemia Market Size Market Share by Application (2017-2022)
Table 10. Global Alpha Thalassemia Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Alpha Thalassemia Revenue Market Share by Player (2020-2022)
Table 12. Alpha Thalassemia Key Players Head office and Products Offered
Table 13. Alpha Thalassemia Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Alpha Thalassemia Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Alpha Thalassemia Market Size Market Share by Regions (2017-2022)
Table 18. Americas Alpha Thalassemia Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Alpha Thalassemia Market Size Market Share by Country (2017-2022)
Table 20. Americas Alpha Thalassemia Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Alpha Thalassemia Market Size Market Share by Type (2017-2022)
Table 22. Americas Alpha Thalassemia Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Alpha Thalassemia Market Size Market Share by Application (2017-2022)
Table 24. APAC Alpha Thalassemia Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Alpha Thalassemia Market Size Market Share by Region (2017-2022)
Table 26. APAC Alpha Thalassemia Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Alpha Thalassemia Market Size Market Share by Type (2017-2022)
Table 28. APAC Alpha Thalassemia Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Alpha Thalassemia Market Size Market Share by Application (2017-2022)
Table 30. Europe Alpha Thalassemia Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Alpha Thalassemia Market Size Market Share by Country (2017-2022)
Table 32. Europe Alpha Thalassemia Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Alpha Thalassemia Market Size Market Share by Type (2017-2022)
Table 34. Europe Alpha Thalassemia Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Alpha Thalassemia Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Alpha Thalassemia Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Alpha Thalassemia Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Alpha Thalassemia Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Alpha Thalassemia Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Alpha Thalassemia Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Alpha Thalassemia Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Alpha Thalassemia
Table 43. Key Market Challenges & Risks of Alpha Thalassemia
Table 44. Key Industry Trends of Alpha Thalassemia
Table 45. Global Alpha Thalassemia Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Alpha Thalassemia Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Alpha Thalassemia Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Alpha Thalassemia Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Alpha Thalassemia Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Alpha Thalassemia Market Size Market Share Forecast by Application (2023-2028)
Table 51. Bluebird Bio Details, Company Type, Alpha Thalassemia Area Served and Its Competitors
Table 52. Bluebird Bio Alpha Thalassemia Product Offered
Table 53. Bluebird Bio Alpha Thalassemia Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Bluebird Bio Main Business
Table 55. Bluebird Bio Latest Developments
Table 56. Novartis Details, Company Type, Alpha Thalassemia Area Served and Its Competitors
Table 57. Novartis Alpha Thalassemia Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Alpha Thalassemia Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Novartis Latest Developments
Table 61. Kiadis Pharma Details, Company Type, Alpha Thalassemia Area Served and Its Competitors
Table 62. Kiadis Pharma Alpha Thalassemia Product Offered
Table 63. Kiadis Pharma Main Business
Table 64. Kiadis Pharma Alpha Thalassemia Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Kiadis Pharma Latest Developments
Table 66. Acceleron Pharma Details, Company Type, Alpha Thalassemia Area Served and Its Competitors
Table 67. Acceleron Pharma Alpha Thalassemia Product Offered
Table 68. Acceleron Pharma Main Business
Table 69. Acceleron Pharma Alpha Thalassemia Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Acceleron Pharma Latest Developments
List of Figures
Figure 1. Alpha Thalassemia Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Alpha Thalassemia Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Alpha Thalassemia Market Size Market Share by Type in 2021
Figure 7. Alpha Thalassemia in Hospitals
Figure 8. Global Alpha Thalassemia Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Alpha Thalassemia in Private Clinics
Figure 10. Global Alpha Thalassemia Market: Private Clinics (2017-2022) & ($ Millions)
Figure 11. Alpha Thalassemia in Other
Figure 12. Global Alpha Thalassemia Market: Other (2017-2022) & ($ Millions)
Figure 13. Global Alpha Thalassemia Market Size Market Share by Application in 2021
Figure 14. Global Alpha Thalassemia Revenue Market Share by Player in 2021
Figure 15. Global Alpha Thalassemia Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Alpha Thalassemia Market Size 2017-2022 ($ Millions)
Figure 17. APAC Alpha Thalassemia Market Size 2017-2022 ($ Millions)
Figure 18. Europe Alpha Thalassemia Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Alpha Thalassemia Market Size 2017-2022 ($ Millions)
Figure 20. Americas Alpha Thalassemia Value Market Share by Country in 2021
Figure 21. Americas Alpha Thalassemia Consumption Market Share by Type in 2021
Figure 22. Americas Alpha Thalassemia Market Size Market Share by Application in 2021
Figure 23. United States Alpha Thalassemia Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Alpha Thalassemia Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Alpha Thalassemia Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Alpha Thalassemia Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Alpha Thalassemia Market Size Market Share by Region in 2021
Figure 28. APAC Alpha Thalassemia Market Size Market Share by Application in 2021
Figure 29. China Alpha Thalassemia Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Alpha Thalassemia Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Alpha Thalassemia Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Alpha Thalassemia Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Alpha Thalassemia Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Alpha Thalassemia Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Alpha Thalassemia Market Size Market Share by Country in 2021
Figure 36. Europe Alpha Thalassemia Market Size Market Share by Type in 2021
Figure 37. Europe Alpha Thalassemia Market Size Market Share by Application in 2021
Figure 38. Germany Alpha Thalassemia Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Alpha Thalassemia Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Alpha Thalassemia Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Alpha Thalassemia Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Alpha Thalassemia Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Alpha Thalassemia Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Alpha Thalassemia Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Alpha Thalassemia Market Size Market Share by Application in 2021
Figure 46. Egypt Alpha Thalassemia Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Alpha Thalassemia Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Alpha Thalassemia Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Alpha Thalassemia Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Alpha Thalassemia Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Alpha Thalassemia Market Size 2023-2028 ($ Millions)
Figure 52. APAC Alpha Thalassemia Market Size 2023-2028 ($ Millions)
Figure 53. Europe Alpha Thalassemia Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Alpha Thalassemia Market Size 2023-2028 ($ Millions)
Figure 55. United States Alpha Thalassemia Market Size 2023-2028 ($ Millions)
Figure 56. Canada Alpha Thalassemia Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Alpha Thalassemia Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Alpha Thalassemia Market Size 2023-2028 ($ Millions)
Figure 59. China Alpha Thalassemia Market Size 2023-2028 ($ Millions)
Figure 60. Japan Alpha Thalassemia Market Size 2023-2028 ($ Millions)
Figure 61. Korea Alpha Thalassemia Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Alpha Thalassemia Market Size 2023-2028 ($ Millions)
Figure 63. India Alpha Thalassemia Market Size 2023-2028 ($ Millions)
Figure 64. Australia Alpha Thalassemia Market Size 2023-2028 ($ Millions)
Figure 65. Germany Alpha Thalassemia Market Size 2023-2028 ($ Millions)
Figure 66. France Alpha Thalassemia Market Size 2023-2028 ($ Millions)
Figure 67. UK Alpha Thalassemia Market Size 2023-2028 ($ Millions)
Figure 68. Italy Alpha Thalassemia Market Size 2023-2028 ($ Millions)
Figure 69. Russia Alpha Thalassemia Market Size 2023-2028 ($ Millions)
Figure 70. Spain Alpha Thalassemia Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Alpha Thalassemia Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Alpha Thalassemia Market Size 2023-2028 ($ Millions)
Figure 73. Israel Alpha Thalassemia Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Alpha Thalassemia Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Alpha Thalassemia Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
